| Vivian Sheila Dungan, | |
|
32237 Agua Dulce Rd, Agua Dulce, CA 91390 | |
| (818) 371-8313 | |
| Not Available |
| Full Name | Vivian Sheila Dungan |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Family |
| Location | 32237 Agua Dulce Rd, Agua Dulce, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811452030 | NPI | - | NPPES |
| 358986 | Other | CA | LICENSE NUMBER |
| 358986 | Other | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0810X | Clinical Nurse Specialist - Psychiatric/mental Health, Child & Family | 358986 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vivian Sheila Dungan, 32237 Agua Dulce Rd, Agua Dulce, CA 91390 Ph: (818) 371-8313 | Vivian Sheila Dungan, 32237 Agua Dulce Rd, Agua Dulce, CA 91390 Ph: (818) 371-8313 |
News Archive
Obesity is "not a choice" and making people feel ashamed of their weight only leaves them feeling worse about themselves, according to a new report.
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.
Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer.
In testimony to the House Energy and Commerce Committee, the secretary of health and human services says problems are not acceptable and her department is working hard to fix it. She also rejects complaints that the law is responsible for recent cancellations by insurers.
Anticonvulsant drugs are increasingly being used to treat low back pain, but a new study in CMAJ finds they are ineffective and can have adverse effects.
› Verified 1 days ago